Nishadil
Signup Signin
Delhi | 25°C (windy)
A Deeper Look at Assembly Biosciences' Latest Financial Journey

A Deeper Look at Assembly Biosciences' Latest Financial Journey
Pelthos Therapeutics Unveils 2025 Financials, Charting Course for Future Innovations

Pelthos Therapeutics Unveils 2025 Financials, Charting Course for Future Innovations
LivePerson Navigates Evolving AI Landscape, Reports Q4 2025 Financials Amidst Strategic Investments

LivePerson Navigates Evolving AI Landscape, Reports Q4 2025 Financials Amidst Strategic Investments
Zscaler's Growth Dilemma: Why Wider Losses Despite Soaring Revenue?

Zscaler's Growth Dilemma: Why Wider Losses Despite Soaring Revenue?
DMG Blockchain Solutions Navigates Q1 2026: A Deep Dive into Their Latest Financials

DMG Blockchain Solutions Navigates Q1 2026: A Deep Dive into Their Latest Financials
Cubical Fin Ser Faces Challenging Quarter: Sales Dip, Profit Reverses to Loss

Cubical Fin Ser Faces Challenging Quarter: Sales Dip, Profit Reverses to Loss
BN Agrochem Faces Steep Financial Reversal in December 2025 Quarter

BN Agrochem Faces Steep Financial Reversal in December 2025 Quarter
Jindal Poly Films: A Dramatic Financial Reversal in Q3 FY26

Jindal Poly Films: A Dramatic Financial Reversal in Q3 FY26
A Rough Patch: Transworld Shipping Lines Sails into Significant Loss for December Quarter

A Rough Patch: Transworld Shipping Lines Sails into Significant Loss for December Quarter
Quadrant Future Tek Navigates Choppy Waters, Reports Significant Standalone Net Loss

Quadrant Future Tek Navigates Choppy Waters, Reports Significant Standalone Net Loss
Auri Grow India: A Deep Dive into a Challenging September 2025 Quarter

Auri Grow India: A Deep Dive into a Challenging September 2025 Quarter
Turning the Page: Twist Bioscience Narrows Losses, Eyes 2026 Profitability with Renewed Vigor

Turning the Page: Twist Bioscience Narrows Losses, Eyes 2026 Profitability with Renewed Vigor
Against the Odds: Urban Company's Surprising Comeback Amidst Market Whirlwinds

Against the Odds: Urban Company's Surprising Comeback Amidst Market Whirlwinds
Unpacking BKV's Q3: The Story Behind the Numbers

Unpacking BKV's Q3: The Story Behind the Numbers
The Green Haze Lingers: Cronos Group's Q3 Report Reveals a Winding Path Ahead

The Green Haze Lingers: Cronos Group's Q3 Report Reveals a Winding Path Ahead
The Urban Company Balancing Act: Growth, Losses, and the Quest for Profitability

The Urban Company Balancing Act: Growth, Losses, and the Quest for Profitability
Amarin's Tumultuous Tides: A Deep Dive into Q3's Financial Currents

Amarin's Tumultuous Tides: A Deep Dive into Q3's Financial Currents
The Golden Riddle: New Gold's Q3 Figures and the Market's Uneasy Dance

The Golden Riddle: New Gold's Q3 Figures and the Market's Uneasy Dance
Turbulence Ahead: SpiceJet's Lingering Salary Delays Spark Employee Distress and Financial Scrutiny

Turbulence Ahead: SpiceJet's Lingering Salary Delays Spark Employee Distress and Financial Scrutiny
GLCL's Q1 FY2025 Sales Plummet 56%, Company Swings to Net Loss

GLCL's Q1 FY2025 Sales Plummet 56%, Company Swings to Net Loss
S Chand & Co Faces Significant Headwinds: Sales Plummet by 20% While Net Profit Dips into Loss in Q1 FY2026

S Chand & Co Faces Significant Headwinds: Sales Plummet by 20% While Net Profit Dips into Loss in Q1 FY2026
Cathay Cineplexes Owner mm2 Asia Plunges into Deeper Loss Amidst Massive Impairment

Cathay Cineplexes Owner mm2 Asia Plunges into Deeper Loss Amidst Massive Impairment
Vivos Therapeutics Navigates Headwinds: A Closer Look at Q2 2025 Performance and Future Outlook

Vivos Therapeutics Navigates Headwinds: A Closer Look at Q2 2025 Performance and Future Outlook
Asian Hotels Navigates Mixed Fortunes: Sales Soar, Net Loss Widens in Q1 FY26

Asian Hotels Navigates Mixed Fortunes: Sales Soar, Net Loss Widens in Q1 FY26
Bit Mining's Shares Plummet: Deeper-Than-Expected Loss Rocks Investor Confidence

Bit Mining's Shares Plummet: Deeper-Than-Expected Loss Rocks Investor Confidence
Tuhura Biosciences Shines in Q2 2025: Strong Financials and Promising Pipeline Advancements Unveiled

Tuhura Biosciences Shines in Q2 2025: Strong Financials and Promising Pipeline Advancements Unveiled
Load more..